Roche Holding AG
RHHVF · SWISS
$475.00+$16.91 (+3.69%)TodayMarket closed ·
Prev close $458.09
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 4.2% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $10.38 | $10.85 | +4.5% |
| Q4 FY25 | $8.84 | $8.53 | −3.5% |
| Q2 FY25 | $10.94 | $11.10 | +1.5% |
| Q4 FY24 | $8.48 | $8.57 | +1.1% |
| Q2 FY24 | $9.34 | $10.23 | +9.6% |
| Q4 FY23 | $8.49 | $8.47 | −0.2% |
| Q2 FY23 | $10.36 | $10.10 | −2.5% |
| Q4 FY22 | $8.90 | $8.54 | −4.0% |
Earnings calls
- Special Call - Roche Holding AG
- ROP.SW - Earnings call Q2 2026
- Shareholder/Analyst Call - Roche Holding AG
- Analyst/Investor Day - Roche Holding AG
- Roche Holding AG, Q1 2026 Sales/ Trading Statement Call, Apr 23, 2026
- Shareholder/Analyst Call - Roche Holding AG
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.